| Stage | IRM | % of rev | GRC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.0B | 100.00% | $193M | 100.00% | IRM ×10.30 |
| Gross profit | $1.1B | 53.45% | $65M | 33.39% | IRM +20.1pp |
| Operating income | $411M | 20.63% | $34M | 17.54% | IRM +3.1pp |
| Pre-tax income | $186M | 9.32% | $30M | 15.44% | GRC +6.1pp |
| Net income | $129M | 6.47% | $23M | 11.75% | GRC +5.3pp |
| Stage | IRM | GRC | Gap · A − B |
|---|---|---|---|
| Revenue | $2.0B100.00% | $193M100.00% | IRM ×10.30 |
| Gross profit | 53.45%$1.1B | 33.39%$65M | IRM +20.1pp |
| Operating income | 20.63%$411M | 17.54%$34M | IRM +3.1pp |
| Pre-tax income | 9.32%$186M | 15.44%$30M | GRC +6.1pp |
| Net income | 6.47%$129M | 11.75%$23M | GRC +5.3pp |
No disclosed counterparties: GRC.
None